YopH inhibits early pro-inflammatory cytokine responses during plague pneumonia

BMC Immunology

Volumn 11, Issue , 2010, Pages

  Cantwell, Angelene M ^a   Bubeck, Sarah S ^a,b   Dube, Peter H ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE CO92 DELTA YOPH; PROTEIN TYROSINE PHOSPHATASE YOPH; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; ANTIBODY; AUTACOID; OUTER MEMBRANE PROTEIN; YOPH PROTEIN, YERSINIA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GENE MUTATION; HISTOPATHOLOGY; LIVER; LUNG INFILTRATE; MOUSE; NONHUMAN; PLAGUE; PNEUMONIA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SPLEEN; WILD TYPE; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; ENZYMOLOGY; FEMALE; GENETICS; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LUNG; LUNG LAVAGE; MICROBIOLOGY; MUTATION; PATHOGENICITY; PATHOLOGY; VIRULENCE; YERSINIA PESTIS;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES; BACTERIAL OUTER MEMBRANE PROTEINS; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; LUNG; MICE; MUTATION; PLAGUE; PROTEIN TYROSINE PHOSPHATASES; TUMOR NECROSIS FACTOR-ALPHA; VIRULENCE; YERSINIA PESTIS;

EID: 77953519103     PISSN: None     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-11-29     Document Type: Article

References (39)

1. Perry RD, Fetherston JD. Yersinia pestis: etiologic agent of plague. Clin Microbiol Rev 1997, 10:35-66. 172914, 8993858.
2. Dennis DT, Meier FT. Plague. Pathology of Emerging Infections 1997, 21-47. Washington DC: American Society for Microbiology, Horsburgh CR, Nelson AM.
3. Inglesby TV, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2000, 283:2281-2290. 10.1001/jama.283.17.2281, 10807389.
4. Bubeck SS, Cantwell AM, Dube PH. Delayed inflammatory response to primary pneumonic plague occurs in both outbred and inbred mice. Infect Immun 2007, 75:697-705. 10.1128/IAI.00403-06, 1828510, 17101642.
5. Lathem WW, Crosby SD, Miller VL, Goldman WE. Progression of primary pneumonic plague: a mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci USA 2005, 102:17786-91. 10.1073/pnas.0506840102, 1308902, 16306265.
6. Cornelis GR, Wolf-Watz H. The Yersinia Yop virulon: a bacterial system for subverting eukaryotic cells. Mol Microbiol 1997, 23:861-867. 10.1046/j.1365-2958.1997.2731623.x, 9076724.
7. Dube P. Interaction of Yersinia with the gut: mechanisms of pathogenesis and immune evasion. Curr Top Microbiol Immunol 2009, 337:61-91. full_text, 19812980.
8. Viboud GI, Bliska JB. Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol 2005, 59:69-89. 10.1146/annurev.micro.59.030804.121320, 15847602.
9. Chimini G, Chavrier P. Function of Rho family proteins in actin dynamics during phagocytosis and engulfment. Nat Cell Biol 2000, 2:E191-6. 10.1038/35036454, 11025683.
10. May RC, Machesky LM. Phagocytosis and the actin cytoskeleton. J Cell Sci 2001, 114:1061-77.
11. Kerschen EJ, Cohen DA, Kaplan AM, Straley SC. The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun 2004, 72:4589-602. 10.1128/IAI.72.8.4589-4602.2004, 470629, 15271919.
12. Black DS, Bliska JB. Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. EMBO J 1997, 16:2730-44. 10.1093/emboj/16.10.2730, 1169883, 9184219.
13. Montagna LG, Ivanov MI, Bliska JB. Identification of residues in the N-terminal domain of the Yersinia tyrosine phosphatase that are critical for substrate recognition. J Biol Chem 2001, 276:5005-11. 10.1074/jbc.M009045200, 11069923.
14. Grosdent N, Maridonneau-Parini I, Sory MP, Cornelis GR. Role of Yops and adhesins in resistance of Yersinia enterocolitica to phagocytosis. Infect Immun 2002, 70:4165-76. 10.1128/IAI.70.8.4165-4176.2002, 128122, 12117925.
15. Sauvonnet N, Lambermont I, van der Bruggen P, Cornelis GR. YopH prevents monocyte chemoattractant protein 1 expression in macrophages and T-cell proliferation through inactivation of the phosphatidylinositol 3-kinase pathway. Mol Microbiol 2002, 45:805-15. 10.1046/j.1365-2958.2002.03053.x, 12139625.
16. Koyasu S. The role of PI3K in immune cells. Nat Immunol 2003, 4:313-9. 10.1038/ni0403-313, 12660731.
17. Bliska JB, Guan K, Dixon JE, Falkow S. A mechanism of bacterial pathogenesis: tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc Natl Acad Sci USA 1991, 88:1187-1191. 10.1073/pnas.88.4.1187, 50982, 1705028.
18. Bubeck SS, Dube PH. Yersinia pestis CO92 delta yopH is a potent live, attenuated plague vaccine. Clin Vaccine Immunol 2007, 14:1235-8. 10.1128/CVI.00137-07, 2043315, 17652523.
19. Fisher ML, Castillo C, Mecsas J. Intranasal inoculation of mice with Yersinia pseudotuberculosis causes a lethal lung infection that is dependent on Yersinia outer proteins and PhoP. Infect Immun 2007, 75:429-42. 10.1128/IAI.01287-06, 1828392, 17074849.
20. Logsdon LK, Mecsas J. The proinflammatory response induced by wild-type Yersinia pseudotuberculosis infection inhibits survival of yop mutants in the gastrointestinal tract and Peyer's patches. Infect Immun 2006, 74:1516-27. 10.1128/IAI.74.3.1516-1527.2006, 1418670, 16495522.
21. Trulzsch K, Sporleder T, Igwe EI, Russmann H, Heesemann J. Contribution of the major secreted yops of Yersinia enterocolitica O:8 to pathogenicity in the mouse infection model. Infect Immun 2004, 72:5227-34. 10.1128/IAI.72.9.5227-5234.2004, 517446, 15322017.
22. Dube PH, Revell PA, Chaplin DD, Lorenz RG, Miller VL. A role for IL-1 alpha in inducing pathologic inflammation during bacterial infection. Proc Natl Acad Sci USA 2001, 98:10880-10885. 10.1073/pnas.191214498, 58568, 11526216.
23. Dube PH, Handley SA, Lewis J, Miller VL. Protective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines. Infect Immun 2004, 72:3561-70. 10.1128/IAI.72.6.3561-3570.2004, 415655, 15155665.
24. Dube PH, Handley SA, Revell PA, Miller VL. The rovA mutant of Yersinia enterocolitica displays differential degrees of virulence depending on the route of infection. Infect Immun 2003, 71:3512-20. 10.1128/IAI.71.6.3512-3520.2003, 155726, 12761136.
25. Hardy RD, Coalson JJ, Peters J, Chaparro A, Techasaensiri C, Cantwell AM, Kannan TR, Baseman JB, Dube PH. Analysis of pulmonary inflammation and function in the mouse and baboon after exposure to Mycoplasma pneumoniae CARDS toxin. PLoS One 2009, 4:e7562. 10.1371/journal.pone.0007562, 2762541, 19859545.
26. Sebbane F, Gardner D, Long D, Gowen BB, Hinnebusch BJ. Kinetics of disease progression and host response in a rat model of bubonic plague. Am J Pathol 2005, 166:1427-39. 1606397, 15855643.
27. Cornelis GR. Yersinia type III secretion: send in the effectors. J Cell Biol 2002, 158:401-8. 10.1083/jcb.200205077, 2173816, 12163464.
28. Rebeil R, Ernst RK, Gowen BB, Miller SI, Hinnebusch BJ. Variation in lipid A structure in the pathogenic yersiniae. Mol Microbiol 2004, 52:1363-73. 10.1111/j.1365-2958.2004.04059.x, 15165239.
29. Montminy SW, Khan N, McGrath S, Walkowicz MJ, Sharp F, Conlon JE, Fukase K, Kusumoto S, Sweet C, Miyake K, et al. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 2006, 7:1066-73. 10.1038/ni1386, 16980981.
30. Barton ES, White DW, Cathelyn JS, Brett-McClellan KA, Engle M, Diamond MS, Miller VL, HWt V. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature 2007, 447:326-9. 10.1038/nature05762, 17507983.
31. Black DS, Montagna LG, Zitsmann S, Bliska JB. Identification of an amino-terminal substrate-binding domain in the Yersinia tyrosine phosphatase that is required for efficient recognition of focal adhesion targets. Mol Microbiol 1998, 29:1263-74. 10.1046/j.1365-2958.1998.01014.x, 9767593.
32. Bliska JB, Galan JE, Falkow S. Signal transduction in the mammalian cell during bacterial attachment and entry. Cell 1993, 73:903-920. 10.1016/0092-8674(93)90270-Z, 8500180.
33. Parkhill J, Wren BW, Thomson NR, Titball RW, Holden MT, Prentice MB, Sebaihia M, James KD, Churcher C, Mungall KL, et al. Genome sequence of Yersinia pestis, the causative agent of plague. Nature 2001, 413:523-7. 10.1038/35097083, 11586360.
34. Andrews HL, Vogel JP, Isberg RR. Identification of linked Legionella pneumophila genes essential for intracellular growth and evasion of the endocytic pathway. Infect Immun 1998, 66:950-8. 108001, 9488381.
35. Merriam JJ, Mathur R, Maxfield-Boumil R, Isberg RR. Analysis of the Legionella pneumophila fliI gene: intracellular growth of a defined mutant defective for flagellum biosynthesis. Infect Immun 1997, 65:2497-501. 175352, 9169800.
36. Darwin A, Miller V. Identification of Yersinia enterocolitica genes affecting survival in an animal host using signature-tagged transposon mutagenesis. Mol Microbiol 1999, 32:51-62. 10.1046/j.1365-2958.1999.01324.x, 10216859.
37. Dube P, DeCostanzo A, Konopka JB. Interaction between transmembrane domains five and six of the alpha -factor receptor. J Biol Chem 2000, 275:26492-9. 10.1074/jbc.M002767200, 10846179.
38. Guinet F, Carniel E. A technique of intradermal injection of Yersinia to study Y. pestis physiopathology. Adv Exp Med Biol 2003, 529:73-8. full_text, 12756731.
39. Handley SA, Dube PH, Revell PA, Miller VL. Characterization of oral Yersinia enterocolitica infection in three different strains of inbred mice. Infect Immun 2004, 72:1645-56. 10.1128/IAI.72.3.1645-1656.2004, 355989, 14977972.